Clinical Trial Update: The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updating on free fatty acid reduction and its impact on vascular function in metabolic syndrome; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-02-21